Table 2 The clinical characteristics of study participants in the different TyG index tertiles
Overall (n = 427) | TyG index tertiles < 7.72 (n = 213) | TyG index tertiles ≥ 7.72 (n = 214) | P Value | |
|---|---|---|---|---|
Age (year) | 79.66 ± 9.26 | 79.66 ± 9.26 | 77.82 ± 10.30 | 0.13 |
Smoking (%)158 | 158(37.00%) | 79(37.09%) | 79(36.91%) | 0.35 |
Hypertension (%)299 | 299(70.02%) | 151(70.89%) | 148(69.15%) | 0.40 |
Dyslipidemia (%) | 264(61.83) | 129(60.56) | 135(63.08) | 0.66 |
Diabetes (%)137 | 137(32.08%) | 60(28.16%) | 77(35.98%) | 0.02 |
BMI | 25.45 ± 3.38 | 24.36 ± 2.96 | 26.12 ± 344 | < 0.001 |
Fasting blood glucose, mg/dl | 110.72 ± 39.22 | 96.30 + 20.70 | 116.28 ± 29.83 | < 0.001 |
HbA1c | 6.36 ± 0.88 | 6.32 ± 0.85 | 6.48 + 1.12 | 0.28 |
TC, mg/dl | 160.869 ± 38.47 | 163.08 ± 40 | 172.31 ± 36.15 | 0.05 |
TG, mg/dl | 128.46 (82.82, 171.88) | 120.49 (83.28,166.56) | 310.1 (83.28, 177.2) | < 0.01 |
LDL-C, mg/dl | 93.36 ± 28.27 | 89.78 ± 29.16 | 92.85 ± 27.24 | 0.38 |
HDL-C, mg/dl | 49.92 ± 14.67 | 52.56 ± 13.81 | 45.27 ± 11.12 | < 0.01 |
eGFR-EPI, mL/min/1.73 m2 | 90.23(79.30, 98.42) | 90.10(79.41, 98.24) | 90.37(79.22, 98.59) | 0.72 |
Uric acid, umol/L | 335.24 ± 76.37 | 350.55 ± 77.43 | 327.96 ± 75.19 | 0.01 |
Leiden score | 10.69 ± 0.75 | 9.82 ± 0.62 | 11.58 ± 0.85 | 0.07 |
Statins use (%)262 | 262(61.35%) | 246(61.50) | 16(59.25) | 0.13 |
Ezetimibe use (%)18 | 18(42.15%) | 10(4.69) | 8(3.73) | 0.39 |